Jobio announced on the 4th that it has completed registration of major cosmetic items with the European CPNP (Cosmetic Products Notification Portal) and the UK SCPN (Submit Cosmetic Product Notification).

The European CPNP and UK SCPN are regulatory procedures that must be completed to officially distribute cosmetics in the EU and UK, requiring registration and approval of product ingredients and safety information.

With this registration, Jobio has secured the conditions to officially sell in 32 EU countries and the UK market. The registration process was conducted through the Korea Testing Laboratory (KTL), and the company was selected for the Advanced Bio-Material Commercialization Support Project this year, receiving government support to verify products according to international standards.

In particular, Jobio is strengthening its global market strategy by collaborating with Wellpharmtech, which has expanded its business in the healthcare sector, including cosmetics and medical devices. The two companies previously signed a memorandum of understanding for research, development, and business expansion, and plan to jointly pursue commercialization strategies after entering the European market, based on Jobio's bio and biotechnology capabilities and Wellpharmtech's manufacturing and sales infrastructure.

A Jobio representative stated, "Having established a foundation for entering the European market through CPNP and SCPN registration, we will create tangible business results in the global market through collaboration with Wellpharmtech," adding, "We plan to expand our product portfolio to meet overseas consumer demands, focusing on high-value-added bio materials."

A Wellpharmtech representative also noted, "Jobio's technological capabilities can create significant synergy with our cosmetics and medical device business," and expressed intentions to "strengthen the joint commercialization model in the global healthcare market, including the European market."

Popular News